Summary
- Aragen Life Sciences Limited has proposed an initial public offering (IPO) of equity shares exceeding ₹800 crore.
- The IPO includes a fresh issue aggregating to ₹800 crore and an offer for sale of up to 27,329,192 equity shares by selling shareholders.
- Cyril Amarchand Mangaldas is advising Aragen Life Sciences on this significant financial move.
- This IPO marks a crucial step for Aragen as it seeks to enhance its capital base and expand operations.
Join the discussion — sign up to comment, upvote, and save articles.